234 related articles for article (PubMed ID: 6488158)
1. Selective inhibition of prostatic tumor 5 alpha-reductase by a 4-methyl-4-azasteroid.
Kadohama N; Karr JP; Murphy GP; Sandberg AA
Cancer Res; 1984 Nov; 44(11):4947-54. PubMed ID: 6488158
[TBL] [Abstract][Full Text] [Related]
2. Retardation of prostate tumor progression in the Noble rat by 4-methyl-4-aza-steroidal inhibitors of 5 alpha-reductase.
Kadohama N; Wakisaka M; Kim U; Karr JP; Murphy GP; Sandberg AA
J Natl Cancer Inst; 1985 Feb; 74(2):475-86. PubMed ID: 3856054
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of 5 alpha-reductase, receptor binding, and nuclear uptake of androgens in the prostate by a 4-methyl-4-aza-steroid.
Liang T; Heiss CE
J Biol Chem; 1981 Aug; 256(15):7998-8005. PubMed ID: 7263637
[TBL] [Abstract][Full Text] [Related]
4. 4-Azasteroidal 5 alpha-reductase inhibitors without affinity for the androgen receptor.
Liang T; Heiss CE; Cheung AH; Reynolds GF; Rasmusson GH
J Biol Chem; 1984 Jan; 259(2):734-9. PubMed ID: 6693392
[TBL] [Abstract][Full Text] [Related]
5. 12. Androgens: Pharmacodynamics and antagonists. Biochemical and biological studies with 4-aza-steroidal 5 alpha-reductase inhibitors.
Liang T; Rasmusson GH; Brooks JR
J Steroid Biochem; 1983 Jul; 19(1A):385-90. PubMed ID: 6887871
[TBL] [Abstract][Full Text] [Related]
6. Lack of evidence for aromatase in human prostatic tissues: effects of 4-hydroxyandrostenedione and other inhibitors on androgen metabolism.
Brodie AM; Son C; King DA; Meyer KM; Inkster SE
Cancer Res; 1989 Dec; 49(23):6551-5. PubMed ID: 2479464
[TBL] [Abstract][Full Text] [Related]
7. The effect of a 5 alpha-reductase inhibitor on androgen-mediated growth of the dog prostate.
Wenderoth UK; George FW; Wilson JD
Endocrinology; 1983 Aug; 113(2):569-73. PubMed ID: 6872940
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT
Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707
[TBL] [Abstract][Full Text] [Related]
9. 19-nor-10-azasteroids: a novel class of inhibitors for human steroid 5alpha-reductases 1 and 2.
Guarna A; Belle C; Machetti F; Occhiato EG; Payne AH; Cassiani C; Comerci A; Danza G; De Bellis A; Dini S; Marrucci A; Serio M
J Med Chem; 1997 Mar; 40(7):1112-29. PubMed ID: 9089333
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by a 4-methyl-4-aza-steroid of NADPH: delta 4-3-oxosteroid-5 alpha-oxido-reductase activity in cultured interstitial cells derived from immature rat testis.
Verhoeven G; Cailleau J
J Steroid Biochem; 1983 Mar; 18(3):365-7. PubMed ID: 6857752
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of 3 beta-hydroxysteroid-dehydrogenase: an approach for prostate cancer treatment?
Geldof AA; Dijkstra I; Newling DW; Rao BR
Anticancer Res; 1995; 15(4):1349-54. PubMed ID: 7654020
[TBL] [Abstract][Full Text] [Related]
12. Species differences in prostatic steroid 5 alpha-reductases of rat, dog, and human.
Liang T; Cascieri MA; Cheung AH; Reynolds GF; Rasmusson GH
Endocrinology; 1985 Aug; 117(2):571-9. PubMed ID: 4017948
[TBL] [Abstract][Full Text] [Related]
13. Effect of a 4-methyl-4-aza steroid on androgen metabolism by rat ventral prostate epithelial and stromal cell cultures: selective inhibition of 5 alpha-reductase activity.
Orlowski J; Clark AF
Prostate; 1988; 13(4):289-97. PubMed ID: 3217276
[TBL] [Abstract][Full Text] [Related]
14. Binding of a 4-methyl-4-aza-steroid to 5 alpha-reductase of rat liver and prostate microsomes.
Liang T; Heiss CE; Ostrove S; Rasmusson GH; Cheung A
Endocrinology; 1983 Apr; 112(4):1460-8. PubMed ID: 6832056
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of 5 alpha-reductase activity and alteration of nuclear testosterone. Dihydrotestosterone ratio in human genital skin fibroblasts.
Berkovitz GD; Brown TR; Migeon CJ
J Androl; 1984; 5(3):171-5. PubMed ID: 6746410
[TBL] [Abstract][Full Text] [Related]
16. Effect of a new 5 alpha-reductase inhibitor on size, histologic characteristics, and androgen concentrations of the canine prostate.
Brooks JR; Berman D; Glitzer MS; Gordon LR; Primka RL; Reynolds GF; Rasmusson GH
Prostate; 1982; 3(1):35-44. PubMed ID: 7079196
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of steroid 5 alpha-reductase from human skin fibroblasts by 17 beta-N,N-diethylcarbamoyl-4-methyl-4-aza-5 alpha-androstan-3-one.
Leshin M; Wilson JD
J Steroid Biochem; 1982 Sep; 17(3):245-50. PubMed ID: 6957692
[TBL] [Abstract][Full Text] [Related]
18. Response of rat ventral prostate to a new and novel 5 alpha-reductase inhibitor.
Brooks JR; Baptista EM; Berman C; Ham EA; Hichens M; Johnston DB; Primka RL; Rasmusson GH; Reynolds GF; Schmitt SM; Arth GE
Endocrinology; 1981 Sep; 109(3):830-6. PubMed ID: 7262023
[No Abstract] [Full Text] [Related]
19. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS
Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738
[TBL] [Abstract][Full Text] [Related]
20. Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 alpha-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate.
Yamashita A; Hayashi N; Sugimura Y; Cunha GR; Kawamura J
Prostate; 1996 Jul; 29(1):1-14. PubMed ID: 8685049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
